Background {#Sec1}
==========

Ewing's sarcoma (ES)/primitive neuroectodermal tumor (PNET) is a small round cell tumor with simple sarcoma-specific genetic alterations resulting in *TET/FET* family member and *ETS* family member fusion proteins \[[@CR1]\]. Pathologists no longer categorize ES and PNET as different tumors because their genetic abnormalities overlap. Instead, they are termed the Ewing's sarcoma family of tumors \[[@CR2], [@CR3]\], together with the Askin tumor. ES/PNET are most commonly seen in patients younger than 20 years of age and are derived mainly from bone \[[@CR4]\]. The tumor has been discovered in most organs, including the pancreas, liver, adrenal gland, esophagus, and uterus \[[@CR5]--[@CR11]\]. However, ES/PNET is extremely rare in the small bowel. Although it has been reported previously in this location \[[@CR12]--[@CR17]\], none of these reports came from China. Here, we present the first reported case in China of primary ES/PNET in the ileum with EWS rearrangement.

Case presentation {#Sec2}
=================

Clinical history {#Sec3}
----------------

A 16-year-old Chinese girl presented complaining of anemia and interval hematochezia. Her hemoglobin was 54 g/L on admission. Capsule endoscopy and double-balloon enteroscopy showed mucosal hyperemia, edema and mass protrusion on the ileal wall. Computed tomography (CT) scans and three-dimensional reconstruction revealed a 10.0 × 7.3 × 5.3 cm irregular mass that had developed from the ileal wall in the right lower quadrant (Fig. [1a](#Fig1){ref-type="fig"}-[h](#Fig1){ref-type="fig"}). The lesion showed intense but inhomogeneous enhancement following contrast administration (Fig. [1e](#Fig1){ref-type="fig"}-[h](#Fig1){ref-type="fig"}), particularly in the arterial phase. There was a small amount of effusion in the pelvic cavity. Pelvic magnetic resonance imaging (MRI) indicated a right ovarian cyst in addition to the above mass. Both CT and MRI prompted suspicion of malignant GIST of the small bowel. Her serum CA-125 was slightly increased (50.5 U/mL, standard 0--36 U/mL), but the other markers were within normal limits. The tumor and a loop of small intestine were resected through a right ventral midline incision. The patient recovered uneventfully. Postoperative bone scintigraphy proved that there was no lesion in the skeletal system (Fig. [1 d](#Fig1){ref-type="fig"}). Her chest CT scan and cerebral MRI were also unremarkable. Thus, the patient was classified as T2aN0M0 according to the 8th edition of the AJCC Cancer Staging Manual.Fig. 1Abdominal and pelvic CT scan, 3D reconstruction and ECT demonstrating the tumor originating in the ileum of the patient. CT scan was performed immediately after enteroscopy. Thus, the patient's intestine was dilated. **a** Coronal scan arterial phase reveals that the tumor was derived from ileal wall. **b** 3D reconstruction with volume rendering technique illustrates the supporting vasculature. **c** 3D reconstruction with maximum intensity projection demonstrates major vascular support of the tumor. **d** Postoperative bone scintigraphy proved that there was no lesion in her skeletal system. **e** Plain scan revealed pelvic a 10.0 × 7.6 × 5.3 cm mass with areas of necrosis. Most of the mass was had clear boundaries with surrounding tissues, although part of it obliterated the lumen of the terminal ileum. Workup for metastasis was negative. **f**-**h** Contrast-enhanced arterial, venous, and delayed phase pelvic CT scan revealed enhancement of the solid part of the tumor in all phases, with the peak in the arterial phase

Gross features {#Sec4}
--------------

On laparotomy, a large cystic and solid mass 10.5 cm in diameter was found arising from the ileal wall. The cut tumor surface showed large central hemorrhagic and necrotic changes and pseudocystic degeneration. The tumor tissue was mostly light gray and solid, with some softer and more friable reddish congested areas (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Gross features of the tumor with the resected ileum

Histological features {#Sec5}
---------------------

Cross sections revealed solid nests of small round tumor cells arising from the muscular layer and infiltrating all layers of the ileum wall. Cystic and hemorrhagic changes were seen on part of the sections, as were sharply demarcated borders that were frequently covered by intact serosa. No vascular tumor embolus or perineuronal invasion were observed. The serosal layer and the surgical margins of the specimen were free of disease. Under high-power view, tumor cells were round or elliptical, possessing scant eosinophilic cytoplasm and abortive pseudorosette formation. The tumor cell nuclei were round, with exquisite chromatin, ambiguous nucleoli, and 9/10 high-power-field pathological mitoses (Fig. [3a](#Fig3){ref-type="fig"}-[c](#Fig3){ref-type="fig"}). Tumor cells showed positive immunoreactivity for Vimentin and CD99 (Fig. [3 d, j](#Fig3){ref-type="fig"}) and moderate staining for Cam5.2, Syn and PR (Fig. [3 f, g, k](#Fig3){ref-type="fig"}). Results were negative for CKpan, LCA, S-100, HMB45, Melan-A, CD31, CD34, NSE, P53, CD56, CgA, SMA, Desmin, CD117, Dog-1, ER, Bcl-2, and alpha-inhibin.Fig. 3Histological and immunohistochemical features of the intestinal tumor. **a** Low-power view with HE staining indicates sheets of tumor cells invading the myometrium and submucosa. **b** High-power HE view suggests that the tumor cells are small, round and form Homer-Wright structures. The boxed region is amplified in the upper right corner and is used to show pathological mitosis. **c**-**f** The tumor is positively stained for Vimentin, Syn, CD99, and the Ki-67 index is high (\~40%). All immunohistochemistry images were taken under 200× magnification

FISH {#Sec6}
----

Dual color break-apart probe FISH examination showed that 90% of the cells (100 counted cells per slide) exhibited 1 yellow and 1 red signal (1F1R) and that 6% of the cells exhibited 1 yellow, 1 red and 1 green (break-apart) signal (1F1G1R). However, only 4% cell had two yellow signals, which proved a break of the *EWSR1* locus (2 F) (Fig. [4a](#Fig4){ref-type="fig"}-[c](#Fig4){ref-type="fig"}).Fig. 4Dual color (*red*/*green*) break-apart probe FISH test of the tumor. **a** Normal karyotype cells have two yellow (*red/green* merged) signals (*arrowheads*). **b** Most tumor cells (90%) had one yellow (*red/green* merged) signal and one red signal (*arrows*). C. Consecutive sections were HE-stained

EM {#Sec7}
--

Transmission electron microscopy revealed dense clusters of tumor cells, interspersed with a few interstitial cells (Fig. [5 a](#Fig5){ref-type="fig"}). The tumor cells were small and irregular, with scant cytoplasm and organelles, and significant nuclear atypia (Fig. [5 a](#Fig5){ref-type="fig"}). Some cells had small nucleoli (Fig. [5 a](#Fig5){ref-type="fig"}). Occasionally, gap junctions between the cells were observed (Fig. [5 b](#Fig5){ref-type="fig"}), but neuroendocrine granules in the cytoplasm were rarely seen (Fig. [5 c](#Fig5){ref-type="fig"}). Most cells had glycogen particles attached to the endoplasmic reticulum (Fig. [5 d](#Fig5){ref-type="fig"}).Fig. 5Ultrastructure analysis of the tumor. **a** At lower magnification, EM shows the general tumor ultrastructure. **b** Cell-cell gap junctions (*blue* arrow) were observed in some areas. **c** Neurosecretory granules (*red* arrow) were rarely seen in the tumor cytoplasm. **d** Glycogen granules (*yellow* arrow) existed in most tumor cells. All bars = 2000 nm

Treatments and outcome {#Sec8}
----------------------

The patient underwent an exploratory laparotomy, and tumor resection was performed along with 60 cm of ileum. The patient refused chemotherapy and/or radiotherapy as adjuvant treatments. She is currently alive (10 months after the surgery) without any signs of recurrence.

Discussion {#Sec9}
==========

ES/PNET belongs to a family of tumors that harbor the *EWSR1*-*ETS* fusion protein, according to recent studies \[[@CR18]\]. It is the second most common pediatric sarcoma of bone. It most commonly arises from bone but can develop in extraskeletal sites \[[@CR19]\]. The *EWSR1* gene, together with several other genes, forms the TET family \[[@CR20]\]. Their motif of RNA binding activity enables the *EWSR1*-*ETS* fusion protein to regulate target genes as transcription factors \[[@CR21], [@CR22]\]. Previous research provided evidence that mesenchymal stem cells may be candidate cells from which ES/PNET originate and that *EWSR1*--*FLI1* may be the sole initiating factor in the pathogenesis of these tumors \[[@CR20], [@CR23]\]. Such expression results in cell transformation, with the subsequent emergence of tumors bearing the morphological and gene expression hallmarks of Ewing's sarcoma \[[@CR24]\].

Gastroenterological ES/PNET is extremely rare. Here, we have summarized all previous publications of gastrointestinal ES/PNET in Table [1](#Tab1){ref-type="table"} \[[@CR7], [@CR12], [@CR13], [@CR17], [@CR25]--[@CR49]\]. Among the 36 cases, 3 cases were derived from the esophagus, 9 from the stomach, 5 were of colorectal origin, and 19 arose from the small intestine. The patient gender ratio (female/male) was 22/14, and the ages ranged from 9 to 68 years. Thirty-one of 32 cases were positive for CD99 immunoreactivity. Fluorescent in situ hybridization or real-time PCR tests confirmed that most cases had the *EWSR1*-*ETS* fusion protein. Intriguingly, however, only 4 non-metastatic gastrointestinal ES/PNET cases were treated only by resection of the tumor. Follow-up of these cases suggested that the patients were relatively younger and had up to 20 months of disease-free survival. In the current case, the young patient also refused to take adjuvant chemo- or radiotherapy. To our delight, after the 10-month follow-up examination, the patient is currently alive and well, without any sign of recurrence.Table 1Review of reported cases of gastrointestinal ES/PNETTumor siteAgeSexCgASynCKCD99CD117FLI1FISH break-apart EWSR1RT--PCR EWS--FLI1Metastasis at diagnosisTreatmentsFollow-upReferenceEsophagus44F\-\--+-+++-CxNDJohnson AD et al.Esophagus56M-ND-+NDNDND+Lymph nodesSx + ImCxNDMaesawa C et al.Esophagus21MNDND\-\--ND+ND-Sx + RxNDKim SB et al.Gastric31FNDND-+ND+-+-Sx + Rx3 years DFSKhuri S et al.Gastric19MNDNDND++NDNDND-CxNDAras M et al.Gastric41F++ND++NDND+Intra-peritonealSx + Cx + RxDied 110 months after surgeryInoue M et al.Gastric30M\-\--+NDNDNDND-Sx6 month DFSAnkouz A er alGastric14M\-\--++NDND+LiverSx + Cx24 months DFSCzekalla R et al.Gastric55M++-++-ND+Lymph nodesSx13 months DFSSong JM et al.Gastric68M-ND-++NDND+LiverSx + CxDied 13 months after diagnosisRafailidis S et al.Peri-gastric44F\-\--++ND+ND-Sx20 months DFSColovic RB et al.Gastric63FNDNDNDNDNDND++-Sx + CxNDMaxwell AM er alColorectal59MND+-+-NDND+Peritoneal disseminationSxDied 7 months after diagnosisKuwabara K et al.Colorectal24F\-\--+NDNDND+-Sx20 months DFSTokudome N et al.Colorectal17M\-\--+NDNDND+-Sx + Cx1 years DFSDrut R er alColorectal34FNDND-+NDNDND+LiverSx + StemCx7 years DFSAboumarzouk OM et al.Colorectal53M-ND-+NDNDNDND-Sx + Cx + RxDied 2 years after diagnosisVardy J et al.Small bowel21FND-++NDNDNDND-Sx + Cx10 months DFSAdair et al.Small bowel20FNDNDND+NDND+\--Sx + Cx18 months DFSKie et al.Small bowel13MND-++NDND+ND-Sx1 years DFSSarangarajan etalSmall bowel40MND+-+NDND+NDIntra-peritonealSx + CxDied with recurrence 5 months after diagnosisHorie and KatoSmall bowel14MND-++NDND++-Sx + Cx10 month DFSGraham et al.Small bowel9F\--+NDNDND++-Sx + CxDied 25 months after diagnosisShek et al.Small bowel53FNDNDND+NDNDNDND-SxNDBalasubram-anina et al.Small bowel63MNDNDND++NDNDNDAdrenal glands + lymph nodesSx + CxNDKim et al.Small bowel44MNDND-+NDNDNDNDIntra-peritonealSx + CxDied 13 months after diagnosisSethi and SmithSmall bowel32MNDNDND+ND++ND-Sx + Cx6 months DFSRodarte Shade et al.Small bowel15FNDNDNDNDNDND++-Sx + CxNDVignail et al.Small bowel18MNDNDNDNDNDNDNDND-Sx + CxNDBoehm et al.Small bowel18M++++++++LiverSxDied 8 months after diagnosisMilione M et al.Small bowel20M++++++++LiverSx + CxDied 28 months after diagnosisMilione M et al.Small bowel42M++++++++-Sx + CxDied 11 months after diagnosisMilione M et al.Small bowel45M++++++++-Sx + CxDied 13 months after diagnosisMilione M et al.Small bowel15F++++++++-Sx + Cx + Rx28 months DFSMilione M et al.Small bowel57M++++++++-LostLostMilione M et al.Small bowel28F++++\--++LiverSx + Cx204 months DFSMilione M et al.*F* Female, *M* Male, *ND* Not done, *Sx* Surgery, *Cx* Chemotherapy, *ImCx* Immuno chemotherapy, *StemCx* Stem cell based chemotherapy, *Rx* Radiotherapy, *DFS* Disease free survival

To date, the 5-year survival rate of localized ES/PNET is relatively high (65%-75%). However, the outcome for metastatic patients is usually poor (\<30%), despite the use of chemo- and/or radiotherapy \[[@CR50]\]. Several studies have indicated that localized extraskeletal ES/PNET has a more favorable outcome than skeletal tumors \[[@CR51], [@CR52]\]. The optimal management for localized ES/PNET is still debated. The National Comprehensive Cancer Network guidelines recommend that any ES/PNET should be treated with local treatment (surgery and/or radiotherapy) plus chemotherapy \[[@CR53]\]. Nevertheless, consistent with our findings in Table [1](#Tab1){ref-type="table"}, others have suggested that complete surgery, if feasible, may be a better option for local disease considering the late side effects of high-dose radiotherapy especially for children \[[@CR52], [@CR54]\]. Because small bowel ES/PNET is extremely rare and difficult to cure, our case will contribute to the understanding of the prognosis and determination of optimal management.

In the current case, the 16-year-old female patient was initially misdiagnosed with malignant GIST because of the clinical symptoms and imaging results. To differentiate among ES/PNET, malignant GIST, clear-cell sarcoma, and synovial sarcoma, immunohistochemistry, ultrastructure analysis and FISH tests were performed. Malignant GIST usually expresses CD117, Dog-1 and CD34, which were all negative in this case. Although both synovial sarcoma and ES/PNET could have genetic rearrangements, the regions of these translocations are quite different. In ES/PNET, Chr22 *EWS-FLI* or *EWS-FEV* translocations are commonly reported \[[@CR16]\]. However, in synovial sarcoma, *SYT-SSX* translocation is frequently observed \[[@CR55]\]. Clear-cell sarcoma could be ruled out by negative immunohistochemistry for HMB45, S-100 and Melan A. A previous study also indicated the necessity of distinguishing from an intraabdominal desmoplastic small round cell tumor (IDSRCT) by histological and immunohistochemical characteristics when ES/PNET occurs in the abdominal cavity \[[@CR13]\].

Previous demographic research has suggested that Ewing's sarcoma is far less frequent in China than in the United States Caucasian population \[[@CR56]\]. However, whether this finding is related to genetic background differences remains to be studied. Two recent publications noted a difference in Ewing's sarcoma occurrence between Caucasian and Hispanic populations \[[@CR57], [@CR58]\]. However, they did not include a reason to explain this differences.

Conclusions {#Sec10}
===========

In conclusion, we have described for the first time a rare case of localized ES/PNET occurring in the small intestine in the Chinese population, as confirmed by ultrastructure and genetic analyses. This case, together with previous reports, has expanded the spectrum of tumors in the small intestine.
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